Abatacept has previously shown beneficial effects in some patients with CTLA-4-insufficiency presenting enteropathy, lymphoproliferation, and autoimmune cytopenias,2,3 and in our patient, abatacept was highly effective, leading to fast and sustained improvement of her systemic symptoms. The gene discussed is CTLA4; the disease is Abnormal intestine morphology.